BLCO
Bausch + Lomb Corp
NYSE: BLCO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$15.34
-2.42% today
Updated 2026-04-29
Market cap
$5.47B
P/E ratio
—
P/S ratio
1.07x
EPS (TTM)
$-0.62
Dividend yield
—
52W range
$11 – $19
Volume
0.4M
Bausch + Lomb Corp (BLCO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $763.00M | $799.00M | $522.00M | $873.00M | $345.00M | $-17.00M | $232.00M | $283.00M |
| Capital expenditures | $101.00M | $180.00M | $259.00M | $193.00M | $175.00M | $181.00M | $291.00M | $349.00M |
| Depreciation | $495.00M | $469.00M | $442.00M | $415.00M | $379.00M | $382.00M | $436.00M | $421.00M |
| Stock-based comp | $43.00M | $50.00M | $50.00M | $62.00M | $62.00M | $74.00M | $92.00M | $149.00M |
| Free cash flow | $662.00M | $619.00M | $263.00M | $680.00M | $170.00M | $-198.00M | $-59.00M | $-66.00M |
| Investing cash flow | $-74.00M | $-186.00M | $-256.00M | $-214.00M | $-215.00M | $-2.11B | $-412.00M | $-455.00M |
| Financing cash flow | $-665.00M | $-606.00M | $-232.00M | $-712.00M | $81.00M | $2.08B | $178.00M | $225.00M |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $211.00M | — | — | — |